FTC’s ‘Awesome’ Suit Against Shire Targets Citizen Petitions

46 filings with FDA were intended to block generic competition, FTC says in its first-ever suit over citizen petitions; role of consultants highlighted.

United States Federal Trade Commission building in Washington, DC

In a striking move, the Federal Trade Commission filed its first enforcement action against a company alleging abuse of FDA’s citizen petition process.

In a Feb. 7 complaint against Shire PLC subsidiary Shire ViroPharma Inc., FTC asserts that the company’s...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet